Improvement of COVID-19 Testing and International Funding will drive the Global Market for COVID-19 Saliva-based Screening over the Forecast Duration

The latest publication by Persistence Market Research on the COVID-19 saliva-based screening market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for COVID-19 saliva-based screening products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the COVID-19 saliva-based screening market. Shareholders in the COVID-19 saliva-based screening market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the COVID-19 saliva-based screening market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the COVID-19 saliva-based screening market offers information divided into five important segments - product, technology, application, end-user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Product

Saliva Collection Kits
Saliva Nucleic Acid Purification Kits
Saliva-based Detection Kits
Rapid Test Kits
PCR-based Kits

By Technology

Direct Sample to PCR
RT-qPCR
Lateral Flow Assays
By Application
COVID-19 Research
COVID-19 Diagnostics

By End User

Diagnostic Laboratories
Hospitals & Clinics
Academic and Research Institutes
Biopharma Companies
Long Term Care Facilities
Home Care Settings
Others

By Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for COVID-19 saliva based screening products over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the COVID-19 saliva based screening market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the COVID-19 saliva-based screening market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the COVID-19 saliva-based screening market are more accurate and reliable.

Product Code: PMRREP32712

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Disease Epidemiology and Number of tests
4.2. Market- New Product Launches and Approvals
4.3. Regulatory Scenario
4.4. Key Promotional Strategies by Manufacturers
4.5. Recent Product Launches
4.6. Product Adoption Analysis by Region
4.7. PESTEL Analysis
4.8. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Industry Outlook
- 5.1.3. Global Infection Prevention Market Overview
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Top Companies Historical Growth
- 5.2.2. Technology Advancements in Screening and diagnostic products
- 5.2.3. New Product Launches
- 5.2.4. Growing Geriatric Population
- 5.2.5. Adoption Rate of Screening kits for COVID-19
- 5.2.6. Increased Funding and Support from the Government
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. 2022 Market Scenario
6.2. COVID-19 and Impact Analysis
- 6.2.1. By Product
- 6.2.2. By Technology
- 6.2.3. By Application
- 6.2.4. By End User
- 6.2.5. By Region

7. Global COVID-19 Saliva-based Screening Market Demand (in Volume) Analysis 2020-2022 and Forecast, 2023-2033

7.1. Historical Market (Volume) Analysis, 2020-2022
7.2. Current and Future Market (Volume) Projections, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis

8. Global COVID-19 Saliva-based Screening Market - Pricing Analysis

8.1. Regional Pricing Analysis By Product
8.2. Global Average Pricing Analysis Benchmark
8.3. Pricing Assumptions

9. Global COVID-19 Saliva-based Screening Market Demand (in Value or Size in US$ Mn) Analysis 2020-2022 and Forecast, 2023-2033

9.1. Historical Market Value (US$ Mn) Analysis, 2020-2022
9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
- 9.2.1. Y-o-Y Growth Trend Analysis
- 9.2.2. Absolute $ Opportunity Analysis

10. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Product

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product, 2020-2022
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2023-2033
- 10.3.1. Saliva collection kits
- 10.3.2. Saliva nucleic acid purification kit
- 10.3.3. Saliva based Detection kits
  - 10.3.3.1. Rapid test kits
  - 10.3.3.2. PCR based kits
10.4. Market Attractiveness Analysis By Product

11. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Technology

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2020-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023-2033
- 11.3.1. Direct sample to PCR
- 11.3.2. RT-qPCR
- 11.3.3. Lateral flow assay
11.4. Market Attractiveness Analysis, By Technology

12. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Application

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis by Application, 2020-2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2023-2033
- 12.3.1. COVID-19 Research
- 12.3.2. COVID-19 Diagnostics
12.4. Market Attractiveness Analysis, By Application

13. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By End User

13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2020-2022
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2023-2033
- 13.3.1. Diagnostic Laboratories
- 13.3.2. Hospitals & Clinics
- 13.3.3. Academic and research Institutes
- 13.3.4. Biopharma Companies
- 13.3.5. Long Term Care Facilities
- 13.3.6. Home Care Settings
- 13.3.7. Others
13.4. Market Attractiveness Analysis, By End User

14. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Region

14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Region, 2020-2022
14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2023-2033
- 14.3.1. North America
- 14.3.2. Latin America
- 14.3.3. Europe
- 14.3.4. South Asia
- 14.3.5. East Asia
- 14.3.6. Oceania
- 14.3.7. Middle East and Africa
14.4. Market Attractiveness Analysis, By Region

15. North America COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2020-2022
15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
- 15.3.1. By Country
  - 15.3.1.1. U.S.
  - 15.3.1.2. Canada
- 15.3.2. By Product
- 15.3.3. By Technology
- 15.3.4. By Application
- 15.3.5. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Technology
- 15.4.4. By Application
- 15.4.5. By End User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Market Trends
15.8. Country-Level Analysis & Forecast
- 15.8.1. U.S. COVID-19 Saliva-based Screening Market
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By Technology
    - 15.8.1.2.3. By Application
    - 15.8.1.2.4. By End User
- 15.8.2. Canada COVID-19 Saliva-based Screening Market
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By Technology
    - 15.8.2.2.3. By Application
    - 15.8.2.2.4. By End User

16. Latin America COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2020-2022
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
- 16.3.1. By Country
  - 16.3.1.1. Mexico
  - 16.3.1.2. Brazil
  - 16.3.1.3. Argentina
  - 16.3.1.4. Rest of Latin America
- 16.3.2. By Product
- 16.3.3. By Technology
- 16.3.4. By Application
- 16.3.5. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Technology
- 16.4.4. By Application
- 16.4.5. By End User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Market Trends
16.8. Country-Level Analysis & Forecast
- 16.8.1. Mexico COVID-19 Saliva-based Screening Market
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By Technology
    - 16.8.1.2.3. By Application
    - 16.8.1.2.4. By End User
- 16.8.2. Brazil COVID-19 Saliva-based Screening Market
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By Technology
    - 16.8.2.2.3. By Application
    - 16.8.2.2.4. By End User
- 16.8.3. Argentina COVID-19 Saliva-based Screening Market
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Product
    - 16.8.3.2.2. By Technology
    - 16.8.3.2.3. By Application
    - 16.8.3.2.4. By End User

17. Europe COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2020-2022
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
- 17.3.1. By Country
  - 17.3.1.1. U.K.
  - 17.3.1.2. Germany
  - 17.3.1.3. Italy
  - 17.3.1.4. France
  - 17.3.1.5. Spain
  - 17.3.1.6. Russia
  - 17.3.1.7. BENELUX
  - 17.3.1.8. Rest of Europe
- 17.3.2. By Product
- 17.3.3. By Technology
- 17.3.4. By Application
- 17.3.5. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Technology
- 17.4.4. By Application
- 17.4.5. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Market Trends
17.8. Country-Level Analysis & Forecast
- 17.8.1. U.K. COVID-19 Saliva-based Screening Market
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By Technology
    - 17.8.1.2.3. By Application
    - 17.8.1.2.4. By End User
- 17.8.2. Germany COVID-19 Saliva-based Screening Market
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By Technology
    - 17.8.2.2.3. By Application
    - 17.8.2.2.4. By End User
- 17.8.3. Italy COVID-19 Saliva-based Screening Market
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Product
    - 17.8.3.2.2. By Technology
    - 17.8.3.2.3. By Application
    - 17.8.3.2.4. By End User
- 17.8.4. France COVID-19 Saliva-based Screening Market
  - 17.8.4.1. Introduction
  - 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.4.2.1. By Product
    - 17.8.4.2.2. By Technology
    - 17.8.4.2.3. By Application
    - 17.8.4.2.4. By End User
- 17.8.5. Spain COVID-19 Saliva-based Screening Market
  - 17.8.5.1. Introduction
  - 17.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.5.2.1. By Product
    - 17.8.5.2.2. By Technology
    - 17.8.5.2.3. By Application
    - 17.8.5.2.4. By End User
- 17.8.6. Russia COVID-19 Saliva-based Screening Market
  - 17.8.6.1. Introduction
  - 17.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.6.2.1. By Product
    - 17.8.6.2.2. By Technology
    - 17.8.6.2.3. By Application
    - 17.8.6.2.4. By End User
- 17.8.7. BENULUX COVID-19 Saliva-based Screening Market
  - 17.8.7.1. Introduction
  - 17.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.7.2.1. By Product
    - 17.8.7.2.2. By Technology
    - 17.8.7.2.3. By Application
    - 17.8.7.2.4. By End User

18. South Asia COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2020-2022
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
- 18.3.1. By Country
  - 18.3.1.1. India
  - 18.3.1.2. Indonesia
  - 18.3.1.3. Malaysia
  - 18.3.1.4. Thailand
  - 18.3.1.5. Rest of South Asia
- 18.3.2. By Product
- 18.3.3. By Technology
- 18.3.4. By Application
- 18.3.5. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Technology
- 18.4.4. By Application
- 18.4.5. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Market Trends
18.8. Country-Level Analysis & Forecast
- 18.8.1. India COVID-19 Saliva-based Screening Market
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Product
    - 18.8.1.2.2. By Technology
    - 18.8.1.2.3. By Application
    - 18.8.1.2.4. By End User
- 18.8.2. Indonesia COVID-19 Saliva-based Screening Market
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Product
    - 18.8.2.2.2. By Technology
    - 18.8.2.2.3. By Application
    - 18.8.2.2.4. By End User
- 18.8.3. Malaysia COVID-19 Saliva-based Screening Market
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.3.2.1. By Product
    - 18.8.3.2.2. By Technology
    - 18.8.3.2.3. By Application
    - 18.8.3.2.4. By End User
- 18.8.4. Thailand COVID-19 Saliva-based Screening Market
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.4.2.1. By Product
    - 18.8.4.2.2. By Technology
    - 18.8.4.2.3. By Application
    - 18.8.4.2.4. By End User

19. East Asia COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2020-2022
19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
- 19.3.1. By Country
  - 19.3.1.1. China
  - 19.3.1.2. Japan
  - 19.3.1.3. South Korea
- 19.3.2. By Product
- 19.3.3. By Technology
- 19.3.4. By Application
- 19.3.5. By End User
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Technology
- 19.4.4. By Application
- 19.4.5. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Market Trends
19.8. Country Level Analysis & Forecast
- 19.8.1. China COVID-19 Saliva-based Screening Market
  - 19.8.1.1. Introduction
  - 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.1.2.1. By Product
    - 19.8.1.2.2. By Technology
    - 19.8.1.2.3. By Application
    - 19.8.1.2.4. By End User
- 19.8.2. Japan COVID-19 Saliva-based Screening Market
  - 19.8.2.1. Introduction
  - 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.2.2.1. By Product
    - 19.8.2.2.2. By Technology
    - 19.8.2.2.3. By Application
    - 19.8.2.2.4. By End User
- 19.8.3. South Korea COVID-19 Saliva-based Screening Market
  - 19.8.3.1. Introduction
  - 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.3.2.1. By Product
    - 19.8.3.2.2. By Technology
    - 19.8.3.2.3. By Application
    - 19.8.3.2.4. By End User

20. Oceania COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2020-2022
20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
- 20.3.1. By Country
  - 20.3.1.1. Australia
  - 20.3.1.2. New Zealand
- 20.3.2. By Product
- 20.3.3. By Technology
- 20.3.4. By Application
- 20.3.5. By End User
20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Product
- 20.4.3. By Technology
- 20.4.4. By Application
- 20.4.5. By End User
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
20.7. Key Market Trends
20.8. Country Level Analysis & Forecast
- 20.8.1. Australia COVID-19 Saliva-based Screening Market
  - 20.8.1.1. Introduction
  - 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.1.2.1. By Product
    - 20.8.1.2.2. By Technology
    - 20.8.1.2.3. By Application
    - 20.8.1.2.4. By End User
- 20.8.2. New Zealand COVID-19 Saliva-based Screening Market
  - 20.8.2.1. Introduction
  - 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.2.2.1. By Product
    - 20.8.2.2.2. By Technology
    - 20.8.2.2.3. By Application
    - 20.8.2.2.4. By End User

21. Middle East and Africa (MEA) COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

21.1. Introduction
21.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2020-2022
21.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023-2033
- 21.3.1. By Country
  - 21.3.1.1. GCC Countries
  - 21.3.1.2. Turkey
  - 21.3.1.3. South Africa
  - 21.3.1.4. North Africa
  - 21.3.1.5. Rest of Middle East and Africa
- 21.3.2. By Product
- 21.3.3. By Technology
- 21.3.4. By Application
- 21.3.5. By End User
21.4. Market Attractiveness Analysis
- 21.4.1. By Country
- 21.4.2. By Product
- 21.4.3. By Technology
- 21.4.4. By Application
- 21.4.5. By End User
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis
21.7. Key Market Trends
21.8. Country Level Analysis & Forecast
- 21.8.1. GCC Countries COVID-19 Saliva-based Screening Market
  - 21.8.1.1. Introduction
  - 21.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 21.8.1.2.1. By Product
    - 21.8.1.2.2. By Technology
    - 21.8.1.2.3. By Application
    - 21.8.1.2.4. By End User
- 21.8.2. Turkey COVID-19 Saliva-based Screening Market
  - 21.8.2.1. Introduction
  - 21.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 21.8.2.2.1. By Product
    - 21.8.2.2.2. By Technology
    - 21.8.2.2.3. By Application
    - 21.8.2.2.4. By End User
- 21.8.3. South Africa COVID-19 Saliva-based Screening Market
  - 21.8.3.1. Introduction
  - 21.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 21.8.3.2.1. By Product
    - 21.8.3.2.2. By Technology
    - 21.8.3.2.3. By Application
    - 21.8.3.2.4. By End User
- 21.8.4. North Africa COVID-19 Saliva-based Screening Market
  - 21.8.4.1. Introduction
  - 21.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 21.8.4.2.1. By Product
    - 21.8.4.2.2. By Technology
    - 21.8.4.2.3. By Application
    - 21.8.4.2.4. By End User

22. Market Structure Analysis

22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
- 22.3.1. Regional footprint of Players
- 22.3.2. Product foot print by Players
- 22.3.3. Channel Foot Print by Players

23. Competition Analysis

23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
- 23.3.1. Thermo Fisher Scientific
  - 23.3.1.1. Company Overview
  - 23.3.1.2. Product Portfolio
  - 23.3.1.3. Sales Footprint
  - 23.3.1.4. Key Financials
  - 23.3.1.5. SWOT Analysis
  - 23.3.1.6. Key Developments
  - 23.3.1.7. Strategy Overview
    - 23.3.1.7.1. Marketing Strategy
    - 23.3.1.7.2. Product Strategy
    - 23.3.1.7.3. Channel Strategy
- 23.3.2. Qiagen
  - 23.3.2.1. Company Overview
  - 23.3.2.2. Product Portfolio
  - 23.3.2.3. Sales Footprint
  - 23.3.2.4. Key Financials
  - 23.3.2.5. SWOT Analysis
  - 23.3.2.6. Key Developments
  - 23.3.2.7. Strategy Overview
    - 23.3.2.7.1. Marketing Strategy
    - 23.3.2.7.2. Product Strategy
    - 23.3.2.7.3. Channel Strategy
- 23.3.3. Hologic
  - 23.3.3.1. Company Overview
  - 23.3.3.2. Product Portfolio
  - 23.3.3.3. Sales Footprint
  - 23.3.3.4. Key Financials
  - 23.3.3.5. SWOT Analysis
  - 23.3.3.6. Key Developments
  - 23.3.3.7. Strategy Overview
    - 23.3.3.7.1. Marketing Strategy
    - 23.3.3.7.2. Product Strategy
    - 23.3.3.7.3. Channel Strategy
- 23.3.4. Takara Bio Inc
  - 23.3.4.1. Company Overview
  - 23.3.4.2. Product Portfolio
  - 23.3.4.3. Sales Footprint
  - 23.3.4.4. Key Financials
  - 23.3.4.5. SWOT Analysis
  - 23.3.4.6. Key Developments
  - 23.3.4.7. Strategy Overview
    - 23.3.4.7.1. Marketing Strategy
    - 23.3.4.7.2. Product Strategy
    - 23.3.4.7.3. Channel Strategy
- 23.3.5. Arcis Biotechnology Limited
  - 23.3.5.1. Company Overview
  - 23.3.5.2. Product Portfolio
  - 23.3.5.3. Sales Footprint
  - 23.3.5.4. Key Financials
  - 23.3.5.5. SWOT Analysis
  - 23.3.5.6. Key Developments
  - 23.3.5.7. Strategy Overview
    - 23.3.5.7.1. Marketing Strategy
    - 23.3.5.7.2. Product Strategy
    - 23.3.5.7.3. Channel Strategy
- 23.3.6. GeneProof
  - 23.3.6.1. Company Overview
  - 23.3.6.2. Product Portfolio
  - 23.3.6.3. Sales Footprint
  - 23.3.6.4. Key Financials
  - 23.3.6.5. SWOT Analysis
  - 23.3.6.6. Key Developments
  - 23.3.6.7. Strategy Overview
    - 23.3.6.7.1. Marketing Strategy
    - 23.3.6.7.2. Product Strategy
    - 23.3.6.7.3. Channel Strategy
- 23.3.7. Abacus ALS
  - 23.3.7.1. Company Overview
  - 23.3.7.2. Product Portfolio
  - 23.3.7.3. Sales Footprint
  - 23.3.7.4. Key Financials
  - 23.3.7.5. SWOT Analysis
  - 23.3.7.6. Key Developments
  - 23.3.7.7. Strategy Overview
    - 23.3.7.7.1. Marketing Strategy
    - 23.3.7.7.2. Product Strategy
    - 23.3.7.7.3. Channel Strategy
- 23.3.8. Chai Inc.
  - 23.3.8.1. Company Overview
  - 23.3.8.2. Product Portfolio
  - 23.3.8.3. Sales Footprint
  - 23.3.8.4. Key Financials
  - 23.3.8.5. SWOT Analysis
  - 23.3.8.6. Key Developments
  - 23.3.8.7. Strategy Overview
    - 23.3.8.7.1. Marketing Strategy
    - 23.3.8.7.2. Product Strategy
    - 23.3.8.7.3. Channel Strategy
- 23.3.9. Kolplast Group
  - 23.3.9.1. Company Overview
  - 23.3.9.2. Product Portfolio
  - 23.3.9.3. Sales Footprint
  - 23.3.9.4. Key Financials
  - 23.3.9.5. SWOT Analysis
  - 23.3.9.6. Key Developments
  - 23.3.9.7. Strategy Overview
    - 23.3.9.7.1. Marketing Strategy
    - 23.3.9.7.2. Product Strategy
    - 23.3.9.7.3. Channel Strategy
- 23.3.10. Lucence Health INc
  - 23.3.10.1. Company Overview
  - 23.3.10.2. Product Portfolio
  - 23.3.10.3. Sales Footprint
  - 23.3.10.4. Key Financials
  - 23.3.10.5. SWOT Analysis
  - 23.3.10.6. Key Developments
  - 23.3.10.7. Strategy Overview
    - 23.3.10.7.1. Marketing Strategy
    - 23.3.10.7.2. Product Strategy
    - 23.3.10.7.3. Channel Strategy
- 23.3.11. Vitagene
  - 23.3.11.1. Company Overview
  - 23.3.11.2. Product Portfolio
  - 23.3.11.3. Sales Footprint
  - 23.3.11.4. Key Financials
  - 23.3.11.5. SWOT Analysis
  - 23.3.11.6. Key Developments
  - 23.3.11.7. Strategy Overview
    - 23.3.11.7.1. Marketing Strategy
    - 23.3.11.7.2. Product Strategy
    - 23.3.11.7.3. Channel Strategy
- 23.3.12. Therma Bright Inc
  - 23.3.12.1. Company Overview
  - 23.3.12.2. Product Portfolio
  - 23.3.12.3. Sales Footprint
  - 23.3.12.4. Key Financials
  - 23.3.12.5. SWOT Analysis
  - 23.3.12.6. Key Developments
  - 23.3.12.7. Strategy Overview
    - 23.3.12.7.1. Marketing Strategy
    - 23.3.12.7.2. Product Strategy
    - 23.3.12.7.3. Channel Strategy
- 23.3.13. ACON Laboratories, Inc
  - 23.3.13.1. Company Overview
  - 23.3.13.2. Product Portfolio
  - 23.3.13.3. Sales Footprint
  - 23.3.13.4. Key Financials
  - 23.3.13.5. SWOT Analysis
  - 23.3.13.6. Key Developments
  - 23.3.13.7. Strategy Overview
    - 23.3.13.7.1. Marketing Strategy
    - 23.3.13.7.2. Product Strategy
    - 23.3.13.7.3. Channel Strategy
- 23.3.14. TODA PHARMA
  - 23.3.14.1. Company Overview
  - 23.3.14.2. Product Portfolio
  - 23.3.14.3. Sales Footprint
  - 23.3.14.4. Key Financials
  - 23.3.14.5. SWOT Analysis
  - 23.3.14.6. Key Developments
  - 23.3.14.7. Strategy Overview
    - 23.3.14.7.1. Marketing Strategy
    - 23.3.14.7.2. Product Strategy
    - 23.3.14.7.3. Channel Strategy
- 23.3.15. Norgen Biotek Corp.
  - 23.3.15.1. Company Overview
  - 23.3.15.2. Product Portfolio
  - 23.3.15.3. Sales Footprint
  - 23.3.15.4. Key Financials
  - 23.3.15.5. SWOT Analysis
  - 23.3.15.6. Key Developments
  - 23.3.15.7. Strategy Overview
    - 23.3.15.7.1. Marketing Strategy
    - 23.3.15.7.2. Product Strategy
    - 23.3.15.7.3. Channel Strategy
- 23.3.16. Assure Tech. (Hangzhou) Co., Ltd
  - 23.3.16.1. Company Overview
  - 23.3.16.2. Product Portfolio
  - 23.3.16.3. Sales Footprint
  - 23.3.16.4. Key Financials
  - 23.3.16.5. SWOT Analysis
  - 23.3.16.6. Key Developments
  - 23.3.16.7. Strategy Overview
    - 23.3.16.7.1. Marketing Strategy
    - 23.3.16.7.2. Product Strategy
    - 23.3.16.7.3. Channel Strategy
- 23.3.17. Beijing Hotgen Biotech Co., Ltd
  - 23.3.17.1. Company Overview
  - 23.3.17.2. Product Portfolio
  - 23.3.17.3. Sales Footprint
  - 23.3.17.4. Key Financials
  - 23.3.17.5. SWOT Analysis
  - 23.3.17.6. Key Developments
  - 23.3.17.7. Strategy Overview
    - 23.3.17.7.1. Marketing Strategy
    - 23.3.17.7.2. Product Strategy
    - 23.3.17.7.3. Channel Strategy
- 23.3.18. Nantong Diagnos Biotechnology Co., Ltd
  - 23.3.18.1. Company Overview
  - 23.3.18.2. Product Portfolio
  - 23.3.18.3. Sales Footprint
  - 23.3.18.4. Key Financials
  - 23.3.18.5. SWOT Analysis
  - 23.3.18.6. Key Developments
  - 23.3.18.7. Strategy Overview
    - 23.3.18.7.1. Marketing Strategy
    - 23.3.18.7.2. Product Strategy
    - 23.3.18.7.3. Channel Strategy
- 23.3.19. NeuMoDx Molecular, Inc.
  - 23.3.19.1. Company Overview
  - 23.3.19.2. Product Portfolio
  - 23.3.19.3. Sales Footprint
  - 23.3.19.4. Key Financials
  - 23.3.19.5. SWOT Analysis
  - 23.3.19.6. Key Developments
  - 23.3.19.7. Strategy Overview
    - 23.3.19.7.1. Marketing Strategy
    - 23.3.19.7.2. Product Strategy
    - 23.3.19.7.3. Channel Strategy
- 23.3.20. KYODO INTERNATIONAL INC.
  - 23.3.20.1. Company Overview
  - 23.3.20.2. Product Portfolio
  - 23.3.20.3. Sales Footprint
  - 23.3.20.4. Key Financials
  - 23.3.20.5. SWOT Analysis
  - 23.3.20.6. Key Developments
  - 23.3.20.7. Strategy Overview
    - 23.3.20.7.1. Marketing Strategy
    - 23.3.20.7.2. Product Strategy
    - 23.3.20.7.3. Channel Strategy
- 23.3.21. Canvax
  - 23.3.21.1. Company Overview
  - 23.3.21.2. Product Portfolio
  - 23.3.21.3. Sales Footprint
  - 23.3.21.4. Key Financials
  - 23.3.21.5. SWOT Analysis
  - 23.3.21.6. Key Developments
  - 23.3.21.7. Strategy Overview
    - 23.3.21.7.1. Marketing Strategy
    - 23.3.21.7.2. Product Strategy
    - 23.3.21.7.3. Channel Strategy
- 23.3.22. Zymo Research Corporation.
  - 23.3.22.1. Company Overview
  - 23.3.22.2. Product Portfolio
  - 23.3.22.3. Sales Footprint
  - 23.3.22.4. Key Financials
  - 23.3.22.5. SWOT Analysis
  - 23.3.22.6. Key Developments
  - 23.3.22.7. Strategy Overview
    - 23.3.22.7.1. Marketing Strategy
    - 23.3.22.7.2. Product Strategy
    - 23.3.22.7.3. Channel Strategy
- 23.3.23. Salimetrics
  - 23.3.23.1. Company Overview
  - 23.3.23.2. Product Portfolio
  - 23.3.23.3. Sales Footprint
  - 23.3.23.4. Key Financials
  - 23.3.23.5. SWOT Analysis
  - 23.3.23.6. Key Developments
  - 23.3.23.7. Strategy Overview
    - 23.3.23.7.1. Marketing Strategy
    - 23.3.23.7.2. Product Strategy
    - 23.3.23.7.3. Channel Strategy
- 23.3.24. NEST Scientific USA
  - 23.3.24.1. Company Overview
  - 23.3.24.2. Product Portfolio
  - 23.3.24.3. Sales Footprint
  - 23.3.24.4. Key Financials
  - 23.3.24.5. SWOT Analysis
  - 23.3.24.6. Key Developments
  - 23.3.24.7. Strategy Overview
    - 23.3.24.7.1. Marketing Strategy
    - 23.3.24.7.2. Product Strategy
    - 23.3.24.7.3. Channel Strategy
- 23.3.25. Miraclean Technology Co. Ltd
  - 23.3.25.1. Company Overview
  - 23.3.25.2. Product Portfolio
  - 23.3.25.3. Sales Footprint
  - 23.3.25.4. Key Financials
  - 23.3.25.5. SWOT Analysis
  - 23.3.25.6. Key Developments
  - 23.3.25.7. Strategy Overview
    - 23.3.25.7.1. Marketing Strategy
    - 23.3.25.7.2. Product Strategy
    - 23.3.25.7.3. Channel Strategy
- 23.3.26. Mawi DNA Technologies
  - 23.3.26.1. Company Overview
  - 23.3.26.2. Product Portfolio
  - 23.3.26.3. Sales Footprint
  - 23.3.26.4. Key Financials
  - 23.3.26.5. SWOT Analysis
  - 23.3.26.6. Key Developments
  - 23.3.26.7. Strategy Overview
    - 23.3.26.7.1. Marketing Strategy
    - 23.3.26.7.2. Product Strategy
    - 23.3.26.7.3. Channel Strategy
- 23.3.27. Cell Projects Ltd.
  - 23.3.27.1. Company Overview
  - 23.3.27.2. Product Portfolio
  - 23.3.27.3. Sales Footprint
  - 23.3.27.4. Key Financials
  - 23.3.27.5. SWOT Analysis
  - 23.3.27.6. Key Developments
  - 23.3.27.7. Strategy Overview
    - 23.3.27.7.1. Marketing Strategy
    - 23.3.27.7.2. Product Strategy
    - 23.3.27.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Product Code: PMRREP32712

List of Tables

Table 01: Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 02: Global COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 03: Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 04: Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 05: Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User
Table 06: North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis 2020-2022 and Forecast 2023-2033, by Country
Table 07: North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 08: North America COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 09: North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 10: North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 11: North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User
Table 12: Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis 2020-2022 and Forecast 2023-2033, by Country
Table 13: Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 14: Latin America COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 15: Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 16: Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 17: Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User
Table 18: Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis 2020-2022 and Forecast 2023-2033, by Country
Table 19: Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 20: Europe COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 21: Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 22: Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 23: Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User
Table 24: South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis 2020-2022 and Forecast 2023-2033, by Country
Table 25: South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 26: South Asia COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 27: South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 28: South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 29: South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User
Table 30: East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis 2020-2022 and Forecast 2023-2033, by Country
Table 31: East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 32: East Asia COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 33: East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 34: East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 35: East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User
Table 36: Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis 2020-2022 and Forecast 2023-2033, by Country
Table 37: Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 38: Oceania COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 39: Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 40: Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 41: Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User
Table 42: MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis 2020-2022 and Forecast 2023-2033, by Country
Table 43: MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Product
Table 44: MEA COVID-19 Saliva-based Screening Market Volume (Units) Analysis and Forecast 2020-2033, by Product
Table 45: MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Technology
Table 46: MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by Application
Table 47: MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast 2020-2033, by End User

List of Figures

Figure 01: Global COVID-19 Saliva-based Screening Market Volume (Units), 2020 - 2022
Figure 02: Global COVID-19 Saliva-based Screening Market Volume (Units) & Y-o-Y Growth (%) Analysis,
Figure 03: COVID-19 Saliva-based Screening Market, Pricing Analysis per unit (US$), in 2022
Figure 04: COVID-19 Saliva-based Screening Market, Pricing Forecast per unit (US$), in 2033
Figure 05: Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 06: Global COVID-19 Saliva-based Screening Market Forecast & Y-o-Y Growth, 2023-2033
Figure 07: Global COVID-19 Saliva-based Screening Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
Figure 08: Global COVID-19 Saliva-based Screening Market Value Share (%) Analysis 2023 and 2033, by Product
Figure 09: Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) Analysis 2023-2033, by Product
Figure 10: Global COVID-19 Saliva-based Screening Market Attractiveness Analysis 2023-2033, by Product
Figure 11: Global COVID-19 Saliva-based Screening Market Value Share (%) Analysis 2022 and 2033, by Technology
Figure 12: Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) Analysis 2022-2033, by Technology
Figure 13: Global COVID-19 Saliva-based Screening Market Attractiveness Analysis 2023-2033, by Technology
Figure 14: Global COVID-19 Saliva-based Screening Market Value Share (%) Analysis 2022 and 2033, by Application
Figure 15: Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) Analysis 2022-2033, by Application
Figure 16: Global COVID-19 Saliva-based Screening Market Attractiveness Analysis 2023-2033, by Application
Figure 17: Global COVID-19 Saliva-based Screening Market Value Share (%) Analysis 2023 and 2033, by End User
Figure 18: Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
Figure 19: Global COVID-19 Saliva-based Screening Market Attractiveness Analysis 2023-2033, by End User
Figure 20: Global COVID-19 Saliva-based Screening Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 21: Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 22: Global COVID-19 Saliva-based Screening Market Attractiveness Analysis 2023-2033, by Region
Figure 23: North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 24: North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Forecast, 2023-2033
Figure 25: North America COVID-19 Saliva-based Screening Market Value Share, by Product (2023 E)
Figure 26: North America COVID-19 Saliva-based Screening Market Value Share, by Technology (2023 E)
Figure 27: North America COVID-19 Saliva-based Screening Market Value Share, by Application (2023 E)
Figure 28: North America COVID-19 Saliva-based Screening Market Value Share, by End User (2023 E)
Figure 29: North America COVID-19 Saliva-based Screening Market Value Share, by Country (2023 E)
Figure 30: North America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Product, 2023-2033
Figure 31: North America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Technology, 2023-2033
Figure 32: North America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Application, 2023-2033
Figure 33: North America COVID-19 Saliva-based Screening Market Attractiveness Analysis by End User, 2023-2033
Figure 34: North America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Country, 2023-2033
Figure 35: U.S. COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 36: Global Vs. U.S. Growth Comparison, 2022 - 2033
Figure 37: U.S. COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 38: U.S. COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 39: U.S. COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 40: U.S. COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 41: Canada COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Canada. Growth Comparison, 2022 - 2033
Figure 43: Canada COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 44: Canada COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 45: Canada COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 46: Canada COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 47: Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 48: Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Forecast, 2023-2033
Figure 49: Latin America COVID-19 Saliva-based Screening Market Value Share, by Product (2023 E)
Figure 50: Latin America COVID-19 Saliva-based Screening Market Value Share, by Technology (2023 E)
Figure 51: Latin America COVID-19 Saliva-based Screening Market Value Share, by Application (2023 E)
Figure 52: Latin America COVID-19 Saliva-based Screening Market Value Share, by End User (2023 E)
Figure 53: Latin America COVID-19 Saliva-based Screening Market Value Share, by Country (2023 E)
Figure 54: Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Product, 2023-2033
Figure 55: Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Technology, 2023-2033
Figure 56: Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Application, 2023-2033
Figure 57: Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis by End User, 2023-2033
Figure 58: Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis by Country, 2023-2033
Figure 59: Mexico COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 60: Global Vs Mexico Growth Comparison, 2022 - 2033
Figure 61: Mexico COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 62: Mexico COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 63: Mexico COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 64: Mexico COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 65: Brazil COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Brazil. Growth Comparison, 2022 - 2033
Figure 67: Brazil COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 68: Brazil COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 69: Brazil COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 70: Brazil COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 71: Argentina COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 72: Global Vs Argentina Growth Comparison, 2022 - 2033
Figure 73: Argentina COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 74: Argentina COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 75: Argentina COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 76: Argentina COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 77: Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 78: Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Forecast, 2023-2033
Figure 79: Europe COVID-19 Saliva-based Screening Market Value Share, by Product (2023 E)
Figure 80: Europe COVID-19 Saliva-based Screening Market Value Share, by Technology (2023 E)
Figure 81: Europe COVID-19 Saliva-based Screening Market Value Share, by Application (2023 E)
Figure 82: Europe COVID-19 Saliva-based Screening Market Value Share, by End User (2023 E)
Figure 83: Europe COVID-19 Saliva-based Screening Market Value Share, by Country (2023 E)
Figure 84: Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis by Product, 2023-2033
Figure 85: Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis by Technology, 2023-2033
Figure 86: Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis by Application, 2023-2033
Figure 87: Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis by End User, 2023-2033
Figure 88: Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis by Country, 2023-2033
Figure 89: UK COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 90: Global Vs. UK Growth Comparison, 2022 - 2033
Figure 91: UK COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 92: UK COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 93: UK COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 94: UK COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 95: Germany COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 96: Global Vs. Germany Growth Comparison, 2022 - 2033
Figure 97: Germany COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 98: Germany COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 99: Germany COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 100: Germany COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 101: Italy COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Italy Growth Comparison, 2022 - 2033
Figure 103: Italy COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 104: Italy COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 105: Italy COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 106: Italy COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 107: France COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 108: Global Vs France Growth Comparison, 2022 - 2033
Figure 109: France COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 110: France COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 111: France COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 112: France COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 113: Spain COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 114: Global Vs Spain Growth Comparison, 2022 - 2033
Figure 115: Spain COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 116: Spain COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 117: Spain COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 118: Spain COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 119: Russia COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 120: Global Vs Russia Growth Comparison, 2022 - 2033
Figure 121: Russia COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 122: Russia COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 123: Russia COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 124: Russia COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 125: BENELUX COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 126: Global Vs BENELUX Growth Comparison, 2022 - 2033
Figure 127: BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 128: BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 129: BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 130: BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 131: East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 132: East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Forecast, 2023-2033
Figure 133: East Asia COVID-19 Saliva-based Screening Market Value Share, by Product (2023 E)
Figure 134: East Asia COVID-19 Saliva-based Screening Market Value Share, by Technology (2023 E)
Figure 135: East Asia COVID-19 Saliva-based Screening Market Value Share, by Application (2023 E)
Figure 136: East Asia COVID-19 Saliva-based Screening Market Value Share, by End User (2023 E)
Figure 137: East Asia COVID-19 Saliva-based Screening Market Value Share, by Country (2023 E)
Figure 138: East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Product, 2023-2033
Figure 139: East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Technology, 2023-2033
Figure 140: East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Application, 2023-2033
Figure 141: East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by End User, 2023-2033
Figure 142: East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Country, 2023-2033
Figure 143: China COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 144: Global Vs. China Growth Comparison, 2022 - 2033
Figure 145: China COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 146: China COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 147: China COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 148: China COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 149: Japan COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 150: Global Vs. Japan Growth Comparison, 2022 - 2033
Figure 151: Japan COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 152: Japan COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 153: Japan COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 154: Japan COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 155: South Korea COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 156: Global Vs South Korea Growth Comparison, 2022 - 2033
Figure 157: South Korea COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 158: South Korea COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 159: South Korea COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 160: South Korea COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 161: South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 162: South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Forecast, 2023-2033
Figure 163: South Asia COVID-19 Saliva-based Screening Market Value Share, by Product (2023 E)
Figure 164: South Asia COVID-19 Saliva-based Screening Market Value Share, by Technology (2023 E)
Figure 165: South Asia COVID-19 Saliva-based Screening Market Value Share, by Application (2023 E)
Figure 166: South Asia COVID-19 Saliva-based Screening Market Value Share, by End User (2023 E)
Figure 167: South Asia COVID-19 Saliva-based Screening Market Value Share, by Country (2023 E)
Figure 168: South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Product, 2023-2033
Figure 169: South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Technology, 2023-2033
Figure 170: South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Application, 2023-2033
Figure 171: South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by End User, 2023-2033
Figure 172: South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis by Country, 2023-2033
Figure 173: India COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 174: Global Vs. India Growth Comparison, 2022 - 2033
Figure 175: India COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 176: India COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 177: India COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 178: India COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 179: Indonesia COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 180: Global Vs. Indonesia Growth Comparison, 2022 - 2033
Figure 181: Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 182: Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 183: Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 184: Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 185: Malaysia COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 186: Global Vs. Malaysia Growth Comparison, 2022 - 2033
Figure 187: Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 188: Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 189: Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 190: Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 191: Thailand COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 192: Global Vs. Thailand Growth Comparison, 2022 - 2033
Figure 193: Thailand COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 194: Thailand COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 195: Thailand COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 196: Thailand COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 197: Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 198: Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Forecast, 2023-2033
Figure 199: Oceania COVID-19 Saliva-based Screening Market Value Share, by Product (2023 E)
Figure 200: Oceania COVID-19 Saliva-based Screening Market Value Share, by Technology (2023 E)
Figure 201: Oceania COVID-19 Saliva-based Screening Market Value Share, by Application (2023 E)
Figure 202: Oceania COVID-19 Saliva-based Screening Market Value Share, by End User (2023 E)
Figure 203: Oceania COVID-19 Saliva-based Screening Market Value Share, by Country (2023 E)
Figure 204: Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis by Product, 2023-2033
Figure 205: Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis by Technology, 2023-2033
Figure 206: Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis by Application, 2023-2033
Figure 207: Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis by End User, 2023-2033
Figure 208: Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis by Country, 2023-2033
Figure 209: Australia COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 210: Global Vs. Australia Growth Comparison, 2022 - 2033
Figure 211: Australia COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 212: Australia COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 213: Australia COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 214: Australia COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 215: New Zealand COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 216: Global Vs New Zealand Growth Comparison, 2022 - 2033
Figure 217: New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 218: New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 219: New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 220: New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 221: Middle East & Africa COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis, 2020-2022
Figure 222: Middle East & Africa COVID-19 Saliva-based Screening Market Value (US$ Mn) Forecast, 2023-2033
Figure 223: Middle East & Africa COVID-19 Saliva-based Screening Market Value Share, by Product (2023 E)
Figure 224: Middle East & Africa COVID-19 Saliva-based Screening Market Value Share, by Technology (2023 E)
Figure 225: Middle East & Africa COVID-19 Saliva-based Screening Market Value Share, by Application (2023 E)
Figure 226: Middle East & Africa COVID-19 Saliva-based Screening Market Value Share, by End User (2023 E)
Figure 227: Middle East & Africa COVID-19 Saliva-based Screening Market Value Share, by Country (2023 E)
Figure 228: Middle East & Africa COVID-19 Saliva-based Screening Market Attractiveness Analysis by Product, 2023-2033
Figure 229: Middle East & Africa COVID-19 Saliva-based Screening Market Attractiveness Analysis by Technology, 2023-2033
Figure 230: Middle East & Africa COVID-19 Saliva-based Screening Market Attractiveness Analysis by Application, 2023-2033
Figure 231: Middle East & Africa COVID-19 Saliva-based Screening Market Attractiveness Analysis by End User, 2023-2033
Figure 232: Middle East & Africa COVID-19 Saliva-based Screening Market Attractiveness Analysis by Country, 2023-2033
Figure 233: GCC Countries COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 234: Global Vs GCC Countries Growth Comparison, 2022 - 2033
Figure 235: GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 236: GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 237: GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 238: GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 239: Turkey COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 240: Global Vs. Turkey Growth Comparison, 2022 - 2033
Figure 241: Turkey COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 242: Turkey COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 243: Turkey COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 244: Turkey COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 245: South Africa COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 246: Global Vs. South Africa Growth Comparison, 2022 - 2033
Figure 247: South Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 248: South Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 249: South Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 250: South Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033
Figure 251: North Africa COVID-19 Saliva-based Screening Market Value Proportion Analysis, 2022
Figure 252: Global Vs North Africa Growth Comparison, 2022 - 2033
Figure 253: North Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2022 & 2033
Figure 254: North Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2022 & 2033
Figure 255: North Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2022 & 2033
Figure 256: North Africa COVID-19 Saliva-based Screening Market Share Analysis (%) by End User, 2022 & 2033

Improvement of COVID-19 Testing and International Funding will drive the Global Market for COVID-19 Saliva-based Screening over the Forecast Duration

Description

Table of Contents

List of Tables

Scope of Report

Key Market Segments

By Product

By Technology

By End User

By Region

Key Questions Answered in Report:

Research Methodology

Table of Contents

1. Executive Summary

2. Market Overview

3. Key Market Trends

4. Key Success Factors

5. Market Background

6. COVID-19 Crisis Analysis

7. Global COVID-19 Saliva-based Screening Market Demand (in Volume) Analysis 2020-2022 and Forecast, 2023-2033

8. Global COVID-19 Saliva-based Screening Market - Pricing Analysis

9. Global COVID-19 Saliva-based Screening Market Demand (in Value or Size in US$ Mn) Analysis 2020-2022 and Forecast, 2023-2033

10. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Product

11. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Technology

12. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Application

13. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By End User

14. Global COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033, By Region

15. North America COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

16. Latin America COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

17. Europe COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

18. South Asia COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

19. East Asia COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

20. Oceania COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

21. Middle East and Africa (MEA) COVID-19 Saliva-based Screening Market Analysis 2020-2022 and Forecast 2023-2033

22. Market Structure Analysis

23. Competition Analysis

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

List of Figures